| Nome |
# |
|
Pharmacokinetics of lopinavir determined with an ELISA test in youths with perinatally acquired HIV, file dfa8b99d-5b66-748b-e053-3a05fe0a3a96
|
232
|
|
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study, file dfa8b9a1-2ea5-748b-e053-3a05fe0a3a96
|
194
|
|
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions : a regional simulation, file dfa8b9a0-d6d3-748b-e053-3a05fe0a3a96
|
167
|
|
Duration of isolation and precautions in immunocompromised patients with COVID-19, file dfa8b9a7-02fb-748b-e053-3a05fe0a3a96
|
160
|
|
CD8+CD28-CD127loCD39+regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection?, file dfa8b9a1-2354-748b-e053-3a05fe0a3a96
|
139
|
|
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir± ribavirin in HIV/HCV co-infected patients, file dfa8b99e-1836-748b-e053-3a05fe0a3a96
|
138
|
|
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA), file dfa8b99f-98be-748b-e053-3a05fe0a3a96
|
131
|
|
HIV-associated neurocognitive impairment in the modern ART era : are we close to discovering reliable biomarkers in the setting of virological suppression?, file dfa8b9a0-75e8-748b-e053-3a05fe0a3a96
|
116
|
|
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors : results from a large observational cohort study (SCOLTA), file dfa8b9a0-9e45-748b-e053-3a05fe0a3a96
|
111
|
|
Integrase inhibitors use and CMV infection predict immune recovery in peolple living with HIV starting first-line therapy, file dfa8b9a3-f36c-748b-e053-3a05fe0a3a96
|
111
|
|
Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a question needing an answer, file dfa8b9a1-5688-748b-e053-3a05fe0a3a96
|
102
|
|
Bloodstream infections in patients living with HIV in the modern cART era, file dfa8b9a1-1653-748b-e053-3a05fe0a3a96
|
101
|
|
Treatment simplification to atazanavir/ritonavir plus lamivudine versus maintenance of atazanavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in virologically-suppressed HIV-1-infected patients : 48-weeks results from a randomized trial (ATLAS-M), file dfa8b998-251f-748b-e053-3a05fe0a3a96
|
96
|
|
Maintenance of viral suppression after optimization therapy from etravirine plus raltegravir to rilpivirine plus dolutegravir in HIV-1-infected patients, file dfa8b9a1-2352-748b-e053-3a05fe0a3a96
|
94
|
|
Bloodstream infections in HIV-infected patients, file dfa8b9a1-3470-748b-e053-3a05fe0a3a96
|
89
|
|
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/ emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia, file dfa8b9a0-e7ab-748b-e053-3a05fe0a3a96
|
88
|
|
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells, file dfa8b9a0-d6cf-748b-e053-3a05fe0a3a96
|
86
|
|
Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital : a 30-year retrospective study, file dfa8b9a1-63b1-748b-e053-3a05fe0a3a96
|
85
|
|
Is it still worthwhile to perform quarterly cd4+ t lymphocyte cell counts on hiv-1 infected stable patients?, file dfa8b9a0-d887-748b-e053-3a05fe0a3a96
|
83
|
|
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo, file dfa8b9a0-d458-748b-e053-3a05fe0a3a96
|
80
|
|
Immunological profile of an infant treated with integrase inhibitor from the neonatal period, file dfa8b9a1-1651-748b-e053-3a05fe0a3a96
|
62
|
|
Onychomadesis in a male patient with secondary syphilis, file dfa8b9a0-d6d7-748b-e053-3a05fe0a3a96
|
61
|
|
HIV-1 RNA quantification in CRF02_AG HIV-1 infection: too easy to make mistakes, file dfa8b9a1-1652-748b-e053-3a05fe0a3a96
|
61
|
|
Time to change the single-centre approach to management of patients with tuberculosis : a novel network platform with automatic data import and data sharing, file dfa8b9a1-2ea3-748b-e053-3a05fe0a3a96
|
59
|
|
Switching to Integrase Inhibitors Unlinked to Weight Increase in Perinatally HIV-Infected Young Adults and Adolescents : A 10-Year Observational Study, file dfa8b9a2-2089-748b-e053-3a05fe0a3a96
|
59
|
|
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy, file dfa8b9a1-10bc-748b-e053-3a05fe0a3a96
|
54
|
|
Aumento del peso nelle persone che vivono con infezione da HIV: ritorno al benessere o effetto indesiderato della terapia antiretrovirale? = Weight gain in people living with HIV infection : return to health or adverse event of antiretroviral therapy?, file dfa8b9a1-9f48-748b-e053-3a05fe0a3a96
|
47
|
|
Rationale for an association between PD1 checkpoint inhibition and therapeutic vaccination against HIV, file dfa8b9a0-d888-748b-e053-3a05fe0a3a96
|
46
|
|
Increasing prevalence of genitourinary schistosomiasis in Europe in the Migrant Era : Neglected no more?, file dfa8b9a1-1650-748b-e053-3a05fe0a3a96
|
46
|
|
Treatment of hepatitis C virus genotype 4 in the DAA era, file dfa8b9a0-d6d1-748b-e053-3a05fe0a3a96
|
44
|
|
Chemotherapy Mass Campaigns and Migratory Flows : An Unexpected Connection, file dfa8b9a0-d4c2-748b-e053-3a05fe0a3a96
|
40
|
|
How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy, file dfa8b9a1-1d00-748b-e053-3a05fe0a3a96
|
40
|
|
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine : Data from the SCOLTA project, file dfa8b9a1-07c5-748b-e053-3a05fe0a3a96
|
38
|
|
Increasing use and accessibility of anti parasitic drugs for migrants with neglected diseases at a time of migratory emergency, file dfa8b9a0-d6ce-748b-e053-3a05fe0a3a96
|
21
|
|
Reducing CD4+ lymphocyte cell monitoring in HIV-1 stable patients: a forecast of the cost saving, file dfa8b9a1-fa1c-748b-e053-3a05fe0a3a96
|
15
|
|
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: different effects in different patients populations : results from a large observational study, file dfa8b9a1-0efc-748b-e053-3a05fe0a3a96
|
11
|
|
Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir, file 0910a575-8216-4c5a-b702-cd805e8fab86
|
9
|
|
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort, file dfa8b9a0-cf7b-748b-e053-3a05fe0a3a96
|
8
|
|
Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature, file dfa8b9a1-2351-748b-e053-3a05fe0a3a96
|
7
|
|
Case report : management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir, file dfa8b9a1-7a44-748b-e053-3a05fe0a3a96
|
7
|
|
Is it time to re-think the use of etravirine in patients with available genotypic resistance test?, file dfa8b9a0-d6d5-748b-e053-3a05fe0a3a96
|
6
|
|
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients : The HIV and Hypertension Study, file dfa8b9a1-059b-748b-e053-3a05fe0a3a96
|
6
|
|
Which patients have greatest need for elvitegravir/cobicistat/ emtricitabine/tenofovirDF-based therapy?, file dfa8b9a0-d456-748b-e053-3a05fe0a3a96
|
5
|
|
Ibalizumab and fostemsavir in the management of heavily pre-treated HIV-infected patients, file dfa8b9a0-d88a-748b-e053-3a05fe0a3a96
|
5
|
|
Pillars of long-term antiretroviral therapy success, file f24e6f33-2703-48d3-a10b-c1558d25f819
|
5
|
|
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals, file dfa8b9a0-cf7a-748b-e053-3a05fe0a3a96
|
4
|
|
Bedaquiline : a new hope for shorter and better anti-tuberculosis regimens, file dfa8b9a1-2ea4-748b-e053-3a05fe0a3a96
|
4
|
|
Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides, file dfa8b9a1-7f2b-748b-e053-3a05fe0a3a96
|
4
|
|
Pneumocystis jirovecii pneumonia in HIV-negative patients, a frequently overlooked problem. A case series from a large Italian center, file 0382d23d-e690-4245-8bad-dfea5d6014fb
|
3
|
|
Weight Gain : A Possible Side Effect of All Antiretrovirals, file dfa8b99a-17fe-748b-e053-3a05fe0a3a96
|
3
|
|
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial, file dfa8b99b-514b-748b-e053-3a05fe0a3a96
|
3
|
|
Pineal Germinoma in a Child with Interferon-γ Receptor 1 Deficiency : Case Report and Literature Review, file dfa8b9a0-cf7c-748b-e053-3a05fe0a3a96
|
3
|
|
Hepatitis C virus direct acting antivirals impact on renal function in the first 4 weeks of treatment, file dfa8b9a0-d6d2-748b-e053-3a05fe0a3a96
|
3
|
|
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Diagnosis and Treatment of Sarcoidosis in an HIV-2-Infected Patient, file dfa8b9a0-d6d6-748b-e053-3a05fe0a3a96
|
3
|
|
Short Communication : Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis?, file dfa8b9a0-d6d8-748b-e053-3a05fe0a3a96
|
3
|
|
Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B, file dfa8b9a0-e59b-748b-e053-3a05fe0a3a96
|
3
|
|
Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides, file dfa8b9a0-f0eb-748b-e053-3a05fe0a3a96
|
3
|
|
Hypertensive versus HIV-infected patients : Who has the greatest target organ damage? Comparison of carotid plaque prevalence, intima media thickness and renal resistive index in the two groups of patients, file dfa8b9a1-1cff-748b-e053-3a05fe0a3a96
|
3
|
|
Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice : the results from HIV-HY study, file dfa8b9a1-4454-748b-e053-3a05fe0a3a96
|
3
|
|
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients : The HIV and Hypertension Study, file dfa8b9a1-81d3-748b-e053-3a05fe0a3a96
|
3
|
|
Treatment simplification to atazanavir/ritonavir plus lamivudine versus maintenance of atazanavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in virologically-suppressed HIV-1-infected patients : 48-weeks results from a randomized trial (ATLAS-M), file dfa8b997-4a3c-748b-e053-3a05fe0a3a96
|
2
|
|
Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice : the results from HIV-HY study, file dfa8b9a0-d886-748b-e053-3a05fe0a3a96
|
2
|
|
Successful antiretroviral therapy by using unusual antiretroviral combinations in
heavily pre-treated patients: two case reports, file dfa8b9a0-d889-748b-e053-3a05fe0a3a96
|
2
|
|
Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimen, file dfa8b9a0-eb98-748b-e053-3a05fe0a3a96
|
2
|
|
How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis, file dfa8b9a1-02ef-748b-e053-3a05fe0a3a96
|
2
|
|
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection : Much Ado About Nothing?, file dfa8b9a1-0598-748b-e053-3a05fe0a3a96
|
2
|
|
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy, file dfa8b9a1-05e5-748b-e053-3a05fe0a3a96
|
2
|
|
Therapeutic management of chronic hepatitis B in clinical Practice: a region-wide survey, file dfa8b9a1-1d01-748b-e053-3a05fe0a3a96
|
2
|
|
Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort, file dfa8b9a4-d85b-748b-e053-3a05fe0a3a96
|
2
|
|
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study, file 505ebc60-5eb8-4f87-9d5c-c215b71d8e65
|
1
|
|
Incident diabetes in course of antiretroviral therapy, file abbe8143-985a-4507-bcfb-67bf4f10717d
|
1
|
|
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA Study, file bd7f60ee-770c-4e8f-8678-f2e4e6e7abc1
|
1
|
|
Treatment simplification to atazanavir/ritonavir plus lamivudine versus maintenance of atazanavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in virologically-suppressed HIV-1-infected patients : 48-weeks results from a randomized trial (ATLAS-M), file dfa8b997-771b-748b-e053-3a05fe0a3a96
|
1
|
|
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience, file dfa8b999-e037-748b-e053-3a05fe0a3a96
|
1
|
|
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison, file dfa8b99b-557c-748b-e053-3a05fe0a3a96
|
1
|
|
Missed opportunities to prevent mother-to-child transmission of HIV in Italy, file dfa8b99d-d3a3-748b-e053-3a05fe0a3a96
|
1
|
|
Immunonutrition in human immunodeficiency virus infection : which populations to target?, file dfa8b9a0-4790-748b-e053-3a05fe0a3a96
|
1
|
|
Predictors of weight gain in patients treated with dolutegravir, file dfa8b9a0-e9a1-748b-e053-3a05fe0a3a96
|
1
|
|
Tigecycline use in hospital and its potential role in infection control, file dfa8b9a0-f29d-748b-e053-3a05fe0a3a96
|
1
|
|
Ligurian Vaccination in HIV Program (LIV in HIV): the experience of Genoa metropolitan area, file dfa8b9a1-0efb-748b-e053-3a05fe0a3a96
|
1
|
|
Bloodstream infections in patients living with HIV infection in the recent cART era: did something change?, file dfa8b9a1-0efd-748b-e053-3a05fe0a3a96
|
1
|
|
Will new antimicrobials overcome resistance among Gram-negatives?, file dfa8b9a1-10c0-748b-e053-3a05fe0a3a96
|
1
|
|
Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status, file dfa8b9a1-164f-748b-e053-3a05fe0a3a96
|
1
|
|
Role of raltegravir in patients co-infected with HIV and HCV in the era of direct antiviral agents, file dfa8b9a1-2353-748b-e053-3a05fe0a3a96
|
1
|
|
The switch from TDF to TAF determines weight gain in patients on rilpivirine-based regimen, file dfa8b9a1-d9a1-748b-e053-3a05fe0a3a96
|
1
|
|
Factors associated with hospital admission for COVID-19 in HIV patients, file dfa8b9a3-e774-748b-e053-3a05fe0a3a96
|
1
|
|
Factors associated with hospital admission for COVID-19 in HIV patients, file dfa8b9a5-239f-748b-e053-3a05fe0a3a96
|
1
|
|
Starting HIV therapy in patients with mitochondrial disease, file dfa8b9a7-d2d3-748b-e053-3a05fe0a3a96
|
1
|
| Totale |
3.250 |